Endogenous sex steroids and cardio- and cerebro-vascular disease in the postmenopausal period

European Journal of Endocrinology

Volumn 167, Issue 2, 2012, Pages 145-156

  Pappa, Theodora ^a   Alevizaki, Maria ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; SEX HORMONE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ESTROGEN BLOOD LEVEL; HEALTH STATUS; HEART DISEASE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC DISORDER; METABOLIC SYNDROME X; MORTALITY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STROKE;

ANIMALS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; FEMALE; GONADAL STEROID HORMONES; HUMANS; POSTMENOPAUSE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84864340936     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0215     Document Type: Review

References (101)

1. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E & Cushman M; Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. New England Journal of Medicine 2003 349 523-534. (doi:10.1056/NEJMoa030808)
2. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S & Mysiw WJ; WHI Investigators. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. Journal of the American Medical Association 2003 289 2673-2684. (doi:10.1001/jama.289.20. 2673)
3. Barrett-Connor E & Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ 1995 311 1193-1196. (doi:10.1136/bmj.311.7014.1193)
4. Price JF, Lee AJ & Fowkes FG. Steroid sex hormones and peripheral arterial disease in the Edinburgh Artery Study. Steroids 1997 62 789-794. (doi:10.1016/S0039-128X(97)00103-7)
5. Shelley JM, Green A, Smith AM, Dudley E, Dennerstein L, Hopper J & Burger H. Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. Annals of Epidemiology 1998 8 39-45. (doi:10.1016/S1047- 2797(97) 00123-3)
6. Roquer J, Campello AR & Gomis M. Sex differences in first-ever acute stroke. Stroke 2003 34 1581-1585. (doi:10.1161/01.STR. 0000078562.82918.F6)
7. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M & Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008 117 e25-e146. (doi:10.1161/ CIRCULATIONAHA.107.187998)
8. Cauley JA, Gutai JP, Glynn NW, Paternostro-Bayles M, Cottington E & Kuller LH. Serum estrone concentrations and coronary artery disease in postmenopausal women. Arteriosclerosis and Thrombosis 1994 14 14-18. (doi:10.1161/01.ATV. 14.1.14)
9. Nilsson SE, Fransson E & Brismar K. Relationship between serum progesterone concentrations and cardiovascular disease, diabetes, and mortality in elderly Swedish men and women: an 8-year prospective study. Gender Medicine 2009 6 433-443. (doi:10.1016/j.genm.2009.09.011)
10. Lee JS, Yaffe K, Lui LY, Cauley J, Taylor B, Browner W & Cummings S; Study of Osteoporotic Fractures Group. Prospective study of endogenous circulating estradiol and risk of stroke in older women. Archives of Neurology 2010 67 195-201. (doi:10. 1001/archneurol.2009.322)
11. Chen Y, Zeleniuch-Jacquotte A, Arslan AA, Wojcik O, Toniolo P, Shore RE, Levitz M & Koenig KL. Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis 2011 216 414-419. (doi:10.1016/j. atherosclerosis.2011.01. 053)
12. Rexrode KM, Manson JE, Lee IM, Ridker PM, Sluss PM, Cook NR & Buring JE. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 2003 108 1688-1693. (doi:10.1161/01.CIR.0000091114.36254.F3)
13. Patel SM, Ratcliffe SJ, Reilly MP, Weinstein R, Bhasin S, Blackman MR, Cauley JA, Sutton-Tyrrell K, Robbins J, Fried LP & Cappola AR. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 2009 94 4776-4784. (doi:10. 1210/jc.2009-0740)
14. Page-Wilson G, Goulart AC & Rexrode KM. Interrelation between sex hormones and plasma sex hormone-binding globulin and hemoglobin A1c in healthy postmenopausal women. Metabolic Syndrome and Related Disorders 2009 7 249-254. (doi:10.1089/ met.2008.0081)
15. Christakou CD & Diamanti-Kandarakis E. Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Women's Health 2008 4 583-594. (doi:10.2217/17455057.4.6.583)
16. Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G & Mastorakos G. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause. Journal of Clinical Endocrinology and Metabolism 2011 96 623-631. (doi:10.1210/jc.2010-0130)
17. Puurunen J, Piltonen T, Morin-Papunen L, Perheentupa A, Järvelä I, Ruokonen A & Tapanainen JS. Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. Journal of Clinical Endocrinology and Metabolism 2011 96 1827-1834. (doi:10.1210/jc.2011- 0039)
18. de Groot PC, Dekkers OM, Romijn JA, Dieben SW & Helmerhorst FM. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Human Reproduction Update 2011 17 495-500. (doi:10.1093/ humupd/dmr001)
19. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W & Pepine CJ. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. Journal of Clinical Endocrinology and Metabolism 2008 93 1276-1284. (doi:10.1210/jc.2007-0425)
20. Wild S, Pierpoint T, McKeigue P & Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clinical Endocrinology 2000 52 595-600. (doi:10.1046/j.1365-2265. 2000.01000.x)
21. Debing E, Peeters E, Duquet W, Poppe K, Velkeniers B & Van den Brande P. Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy. European Journal of Endocrinology 2007 156 687-693. (doi:10.1530/ EJE-06-0702)
22. Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F & Pujia A. Role of endogenous androgens on carotid atherosclerosis in non-obese postmenopausal women. Nutrition, Metabolism, and Cardiovascular Diseases 2007 17 705-711. (doi:10.1016/j. numecd.2006.09.007)
23. Golden SH, Maguire A, Ding J, Crouse JR, Cauley JA, Zacur H & Szklo M. Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. American Journal of Epidemiology 2002 155 437-445. (doi:10.1093/aje/155.5.437)
24. Naessen T, Sjogren U, Bergquist J, Larsson M, Lind L & Kushnir MM. Endogenous steroids measured by high-specificity liquid chromatography-tandem mass spectrometry and prevalent cardiovascular disease in 70-year-old men and women. Journal of Clinical Endocrinology and Metabolism 2010 95 1889- 1897. (doi:10.1210/jc.2009-1722)
25. Laughlin GA, Goodell V & Barrett-Connor E. Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. Journal of Clinical Endocrinology and Metabolism 2010 95 740-747. (doi:10.1210/ jc.2009-1693)
26. Braunstein GD, Johnson BD, Stanczyk FZ, Bittner V, Berga SL, Shaw L, Hodgson TK, Paul-Labrador M, Azziz R & Merz CN. Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease. Journal of Clinical Endocrinology and Metabolism 2008 93 4268-4275. (doi:10.1210/jc.2008-0792)
27. Phillips GB, Pinkernell BH & Jing TY. Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 695-701. (doi:10.1161/01.ATV.17.4.695)
28. Pappa T, Vemmos K, Saltiki K, Mantzou E, Stamatelopoulos K & Alevizaki M. Severity and outcome of acute stroke in women: relation to adrenal sex steroid levels. Metabolism 2012 61 84-91. (doi:10.1016/j.metabol.2011.06. 003)
29. Pappa T, Vemmos K, Mantzou E, Savvari P, Stamatelopoulos K & Alevizaki M. Estradiol levels predict short-term adverse health outcomes in postmenopausal acute stroke women. European Journal of Neurology 2012 In press. (doi:10.1111/j.1468-1331. 2012.03714.x)
30. Saltiki K, Cimponeriu A, Garofalaki M, Sarika L, Papathoma A, Stamatelopoulos K & Alevizaki M. Severity of coronary artery disease in postmenopausal women: association with the androgen receptor gene (CAG)n repeat polymorphism. Menopause 2011 18 1225-1231. (doi:10.1097/gme.0b013e31821b81b8)
31. Alevizaki M, Saltiki K, Cimponeriu A, Kanakakis I, Xita N, Alevizaki CC, Georgiou I & Sarika HL. Severity of cardiovascular disease in postmenopausal women: associations with common estrogen receptor a polymorphic variants. European Journal of Endocrinology 2007 156 489-496. (doi:10.1530/EJE-06-0685)
32. Sievers C, Klotsche J, Pieper L, Schneider HJ, März W, Wittchen HU, Stalla GK & Mantzoros C. Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients. European Journal of Endocrinology 2010 163 699-708. (doi:10. 1530/EJE-10-0307)
33. Maggio M, Ceda GP, Lauretani F, Bandinelli S, Ruggiero C, Guralnik JM, Metter EJ, Ling SM, Paolisso G, Valenti G, Cappola AR & Ferrucci L. Relationship between higher estradiol levels and 9-year mortality in older women: the Invecchiare in Chianti study. Journal of the American Geriatrics Society 2009 57 1810-1815. (doi:10.1111/j.1532-5415.2009.02464.x)
34. Alevizaki M, Saltiki K, Xita N, Cimponeriu A, Stamatelopoulos K, Mantzou E, Doukas C & Georgiou I. The importance of the (TAAAA)n alleles at the SHBG gene promoter for the severity of coronary artery disease in postmenopausal women. Menopause 2008 15 461-468. (doi:10.1097/gme.0b013e31814faf41)
35. Saltiki K, Stamatelopoulos K, Voidonikola P, Lazaros L, Mantzou E, Georgiou I, Anastasiou E, Papamichael C & Alevizaki M. Association of the SHBG gene promoter polymorphism with early markers of atherosclerosis in apparently healthy women. Atherosclerosis 2011 219 205-210. (doi:10. 1016/j.atherosclerosis.2011.06.053)
36. Wu FC & von Eckardstein A. Androgens and coronary artery disease. Endocrine Reviews 2003 24 183-217. (doi:10.1210/er. 2001-0025)
37. Brand JS & van der Schouw YT. Testosterone SHBG and cardiovascular health in postmenopausal women. International Journal of Impotence Research 2010 22 91-104. (doi:10.1038/ijir. 2009.64)
38. Creatsa M, Armeni E, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Alexandrou A, Dendrinos S, Augoulea A, Papamichael C & Lambrinoudaki I. Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women. Metabolism 2012 61 193-201. (doi:10.1016/j.metabol.2011. 06.005)
39. Ouyang P, Vaidya D, Dobs A, Golden SH, Szklo M, Heckbert SR, Kopp P & Gapstur SM. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2009 204 255-261. (doi:10.1016/j.atherosclerosis.2008.08.037)
40. Michos ED, Vaidya D, Gapstur SM, Schreiner PJ, Golden SH, Wong ND, Criqui MH & Ouyang P. Sex hormones, sex hormone binding globulin, and abdominal aortic calcification in women and men in the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 2008 200 432-438. (doi:10.1016/j. atherosclerosis. 2007.12.032)
41. Giallauria F, Ling SM, Schreiber C, Maggio M, Shetty V, Muller D, Vigorito C, Ferrucci L & Najjar SS. Arterial stiffness and bone demineralization: the Baltimore longitudinal study of aging. American Journal of Hypertension 2011 24 970-975. (doi:10. 1038/ajh.2011.80)
42. Munir JA, Wu H, Bauer K, Bindeman J, Byrd C, Feuerstein IM, Villines TC & Taylor AJ. The perimenopausal atherosclerosis transition: relationships between calcified and noncalcified coronary, aortic, and carotid atherosclerosis and risk factors and hormone levels. Menopause 2012 19 10-15. (doi:10.1097/ gme.0b013e318221bc8d)
43. Li XP, Zhou Y, Zhao SP, Gao M, Zhou QC & Li YS. Effect of endogenous estrogen on endothelial function in women with coronary heart disease and its mechanism. Clinica Chimica Acta 2004 339 183-188. (doi:10.1016/j.cccn.2003.10. 006)
44. Wildman RP, Colvin AB, Powell LH, Matthews KA, Everson- Rose SA, Hollenberg S, Johnston JM & Sutton-Tyrrell K. Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN). Menopause 2008 15 414-421. (doi:10.1097/ gme.0b013e318154b6f5)
45. Jeon GH, Kim SH, Yun SC, Chae HD, Kim CH & Kang BM. Association between serum estradiol level and coronary artery calcification in postmenopausal women. Menopause 2010 17 902-907. (doi:10.1097/gme. 0b013e3181d76768)
46. Maturana MA, Rubira MC, Consolim-Colombo F, Irigoyen MC & Spritzer PM. Androgenicity and venous endothelial function in post-menopausal women. Journal of Endocrinological Investigation 2010 33 239-243. (doi:10.3275.6559)
47. Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F & Pujia A. Endogenous testosterone and endothelial function in postmenopausal women. Coronary Artery Disease 2007 18 9-13. (doi:10.1097/01.mca.0000236290.79306.d1)
48. Bernini GP, Sgro' M, Moretti A, Argenio GF, Barlascini CO, Cristofani R & Salvetti A. Endogenous androgens and carotid intimal-medial thickness in women. Journal of Clinical Endocrinology and Metabolism 1999 84 2008-2012. (doi:10.1210/jc.84.6.2008)
49. Calderon-Margalit R, Schwartz SM, Wellons MF, Lewis CE, Daviglus ML, Schreiner PJ, Williams OD, Sternfeld B, Carr JJ, O'Leary DH, Sidney S, Friedlander Y & Siscovick DS. Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: the "Coronary Artery Risk Development in Young Adults" women's study. Journal of Clinical Endocrinology and Metabolism 2010 95 4424-4431. (doi:10.1210/jc.2009-2643)
50. Akishita M, Hashimoto M, Ohike Y, Ogawa S, Iijima K, Eto M & Ouchi Y. Association of plasma dehydroepiandrosterone-sulfate levels with endothelial function in postmenopausal women with coronary risk factors. Hypertension Research 2008 31 69-74. (doi:10.1291/hypres.31.69)
51. Sowers MR, Matthews KA, Jannausch M, Randolph JF, McConnell D, Sutton-Tyrrell K, Little R, Lasley B & Pasternak R. Hemostatic factors and estrogen during the menopausal transition. Journal of Clinical Endocrinology and Metabolism 2005 90 5942-5948. (doi:10.1210/jc.2005-0591)
52. Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S, Pasternak RC, Lloyd-Jones D, Sowers MF & Torréns JI; SWAN Investigators. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005 111 1242-1249. (doi:10.1161/01. CIR.0000157697.54255.CE)
53. Störk S, Bots ML, Grobbee DE & van der Schouw YT. Endogenous sex hormones and C-reactive protein in healthy postmenopausal women. Journal of Internal Medicine 2008 264 245-253. (doi:10. 1111/j.1365-2796.2008.01946.x)
54. Folsom AR, Golden SH, Boland LL & Szklo M. Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women. European Journal of Epidemiology 2005 20 1015-1022. (doi:10.1007/ s10654-005-3657-0)
55. Maturana MA, Breda V, Lhullier F & Spritzer PM. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism 2008 57 961-965. (doi:10.1016/j.metabol.2008.02.012)
56. Joffe HV, Ridker PM, Manson JE, Cook NR, Buring JE & Rexrode KM. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease. Annals of Epidemiology 2006 16 105-112. (doi:10.1016/j. annepidem.2005.07.055)
57. Bell RJ, Davison SL, Papalia MA, McKenzie DP & Davis SR. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Menopause 2007 14 630-638.
58. Khaw KT & Barrett-Connor E. Fasting plasma glucose levels and endogenous androgens in non-diabetic postmenopausal women. Clinical Science 1991 80 199-203.
59. Phillips GB, Tuck CH, Jing TY, Boden-Albala B, Lin IF, Dahodwala N & Sacco RL. Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women. Diabetes Care 2000 23 74-79. (doi:10.2337/diacare.23.1.74)
60. Korytkowski MT, Krug EI, Daly MA, Deriso L, Wilson JW & Winters SJ. Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes? Metabolism 2005 54 1626-1631. (doi:10.1016/j.metabol. 2005.06.011)
61. Oh JY, Barrett-Connor E, Wedick NM & Wingard DL; Rancho Bernardo Study. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 2002 25 55-60. (doi:10.2337/diacare.25.1. 55)
62. Goodman-Gruen D & Barrett-Connor E. Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 2000 23 912-918. (doi:10.2337/diacare.23.7. 912)
63. Ding EL, Song Y, Manson JE, Rifai N, Buring JE & Liu S. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia 2007 50 2076-2084. (doi:10.1007/s00125-007-0785-y)
64. Golden SH, Dobs AS, Vaidya D, Szklo M, Gapstur S, Kopp P, Liu K & Ouyang P. Endogenous sex hormones and glucose tolerance status in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2007 92 1289-1295. (doi:10.1210/ jc.2006-1895)
65. Kalyani RR, Franco M, Dobs AS, Ouyang P, Vaidya D, Bertoni A, Gapstur SM & Golden SH. The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2009 94 4127-4135. (doi:10.1210/jc.2009- 0910)
66. Hudecova M, Holte J, Olovsson M, Larsson A, Berne C & Poromaa IS. Diabetes and impaired glucose tolerance in patients Sex hormones in heart disease and stroke 155 with polycystic ovary syndrome - a long term follow-up. Human Reproduction 2011 26 1462-1468. (doi:10.1093/humrep/der065)
67. Lunde O & Tanbo T. Polycystic ovary syndrome: a follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15-25 years after ovarian wedge resection. Gynecological Endocrinology 2007 23 704-709. (doi:10.1080/0951359 070 1705189)
68. Margolin E, Zhornitzki T, Kopernik G, Kogan S, Schattner A & Knobler H. Polycystic ovary syndrome in post-menopausal women - marker of the metabolic syndrome. Maturitas 2005 50 331-336. (doi:10.1016/j.maturitas.2004.09.005)
69. Elting MW, Korsen TJ, Bezemer PD & Schoemaker J. Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population. Human Reproduction 2001 16 556-560. (doi:10.1093/humrep/ 16.3.556)
70. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Odén A, Janson PO, Mattson LA, Crona N & Lundberg PA. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertility and Sterility 1992 57 505-513. (doi:10.1016/0020-7292(92)90704-M)
71. Berge LN, Bønaa KH & Nordøy A. Serum ferritin, sex hormones, and cardiovascular risk factors in healthy women. Arteriosclerosis and Thrombosis 1994 14 857-861. (doi:10.1161/01.ATV.14.6.857)
72. Lambrinoudaki I, Christodoulakos G, Rizos D, Economou E, Argeitis J, Vlachou S, Creatsa M, Kouskouni E & Botsis D. Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women. European Journal of Endocrinology 2006 154 907-916. (doi:10.1530/eje.1.02167)
73. Haffner SM, Newcomb PA, Marcus PM, Klein BE & Klein R. Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women. American Journal of Epidemiology 1995 142 925-934.
74. Mudali S, Dobs AS, Ding J, Cauley JA, Szklo M & Golden SH; atherosclerosis risk in communities study. Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. Journal of Clinical Endocrinology and Metabolism 2005 90 1202-1209. (doi:10.1210/jc.2004- 0744)
75. Vaidya D, Dobs A, Gapstur SM, Golden SH, Hankinson A, Liu K & Ouyang P. The association of endogenous sex hormones with lipoprotein subfraction profile in the Multi-Ethnic Study of Atherosclerosis. Metabolism 2008 57 782-790. (doi:10.1016/j.metabol.2008.01.019)
76. Shakir YA, Samsioe G, Nyberg P, Lidfeldt J, Nerbrand C & Agardh CD. Do sex hormones influence features of the metabolic syndrome in middle-aged women? A population-based study of Swedish women: the Women's Health in the Lund Area (WHILA) Study. Fertility and Sterility 2007 88 163-171. (doi:10.1016/j. fertnstert.2006.11.111)
77. Sowers M, Crawford SL, Cauley JA & Stein E. Association of lipoprotein(a), insulin resistance, and reproductive hormones in a multiethnic cohort of pre- and perimenopausal women (The SWAN Study). American Journal of Cardiology 2003 92 533-537. (doi:10.1016/S0002-9149(03)00720-3)
78. Mesalić L, Tupković E, Kendić S & Balić D. Correlation between hormonal and lipid status in women in menopause. Bosnian Journal of Basic Medical Sciences 2008 8 188-192.
79. Svendsen OL, Hassager C & Christiansen C. Relationships and independence of body composition, sex hormones, fat distribution and other cardiovascular risk factors in overweight postmenopausal women. International Journal of Obesity and Related Metabolic Disorders 1993 17 459-463.
80. Van Beek AP, de Ruijter-Heijstek FC, Jansen H, Erkelens DW & de Bruin TW. Sex steroids and plasma lipoprotein levels in healthy women: the importance of androgens in the estrogen-deficient state. Metabolism 2004 53 187-192. (doi:10.1016/j.metabol. 2003.07.022)
81. Milewicz A, Zatonska K, Demissie M, Jêdrzejuk D, Dunajska K, Ilow R & Lwow F. Serum adiponectin concentration and cardiovascular risk factors in climacteric women. Gynecological Endocrinology 2005 20 68-73. (doi:10.1080/09513590400020989)
82. Szmuilowicz ED, Adler GK, Ricchiuti V, Hopkins PN & Seely EW. Relationships between endogenous sex hormone concentrations and vascular function in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2007 92 4738-4741. (doi:10.1210/jc.2007-1471)
83. Masi CM, Hawkley LC, Xu X, Veenstra TD & Cacioppo JT. Serum estrogen metabolites and systolic blood pressure among middleaged and older women and men. American Journal of Hypertension 2009 22 1148-1153. (doi:10.1038/ajh.2009. 155)
84. Phillips GB, Jing TY & Laragh JH. Serum sex hormone levels in postmenopausal women with hypertension. Journal of Human Hypertension 1997 11 523-526. (doi:10.1038/sj.jhh.1000481)
85. Janssen I, Powell LH, Kazlauskaite R & Dugan SA. Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study. Obesity 2010 18 604-610. (doi:10.1038/oby.2009.251)
86. Rariy CM, Ratcliffe SJ, Weinstein R, Bhasin S, Blackman MR, Cauley JA, Robbins J, Zmuda JM, Harris TB & Cappola AR. Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the cardiovascular health study. Journal of Clinical Endocrinology and Metabolism 2011 96 989-996. (doi:10.1210/jc.2010- 0926)
87. Mesch VR, Siseles NO, Maidana PN, Boero LE, Sayegh F, Prada M, Royer M, Schreier L, Benencia HJ & Berg GA. Androgens in relationship to cardiovascular risk factors in the menopausal transition. Climacteric 2008 11 509-517. (doi:10.1080/ 13697130802416640)
88. Tufano A, Marzo P, Enrini R, Morricone L, Caviezel F & Ambrosi B. Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause. Journal of Endocrinological Investigation 2004 27 648-653.
89. Hauner H, Bognar E & Blum A. Body fat distribution and its association with metabolic and hormonal risk factors in women with angiographically assessed coronary artery disease. Evidence for the presence of a metabolic syndrome. Atherosclerosis 1994 105 209-216. (doi:10.1016/0021- 9150(94)90051-5)
90. Maturana MA & Spritzer PM. Association between hyperinsulinemia and endogenous androgen levels in peri- and postmenopausal women. Metabolism 2002 51 238-243. (doi:10.1053/ meta.2002.29997)
91. Phillips GB, Jing T & Heymsfield SB. Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women. Metabolism 2008 57 838-844. (doi:10.1016/j.metabol.2008.01. 029)
92. Golden SH, Ding J, Szklo M, Schmidt MI, Duncan BB & Dobs A. Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. American Journal of Epidemiology 2004 160 540-548. (doi:10.1093/aje/kwh250)
93. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Paolisso G, Ble A, Egan JM, Metter EJ, Abbatecola AM, Zuliani G, Ruggiero C, Valenti G, Guralnik JM & Ferrucci L. Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study. American Journal of Physiology. Endocrinology and Metabolism 2007 292 E353-E358. (doi:10.1152/ajpendo.00339.2006)
94. Janssen I, Powell LH, Crawford S, Lasley B & Sutton-Tyrrell K. Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. Archives of Internal Medicine 2008 168 1568-1575. (doi:10.1001/archinte. 168.14.1568)
95. Weinberg ME, Manson JE, Buring JE, Cook NR, Seely EW, Ridker PM & Rexrode KM. Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism 2006 55 1473-1480. (doi:10.1016/j. metabol.2006.06.017)
96. McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar- Rahmani Y, Modugno F, Perri MG, Stanczyk FZ, Van Horn L & Wang CY; Women's Health Initiative Investigators. Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity 2006 14 1662-1677. (doi:10.1038/oby. 2006.191)
97. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P, Shore RE, Krogh V, Koenig KL, Riboli E, Berrino F, Hallmans G, Stattin P, Toniolo P & Kaaks R. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. European Journal of Endocrinology 2004 150 161-171. (doi:10.1530/eje. 0.1500161)
98. Freeman EW, Sammel MD, Lin H & Gracia CR. Obesity and reproductive hormone levels in the transition to menopause. Menopause 2010 17 718-726. (doi:10.1097/gme.0b013e3181 db9f8b)
99. Olson MB, Shaw LJ, Kaizar EE, Kelsey SF, Bittner V, Reis SE, Smith K, Braunstein GD, Berga SL, Johnson BD & Bairey Merz CN; WISE Study Group. Obesity distribution and reproductive hormone levels in women: a report from the NHLBI-sponsored WISE Study. Journal of Women's Health 2006 15 836-842. (doi:10.1089/jwh.2006.15.836)
100. Schmidt J, Landin-Wilhelmsen K, Brännström M & Dahlgren E. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study. Journal of Clinical Endocrinology and Metabolism 2011 96 3794-3803. (doi:10.1210/jc.2011-1677)
101. Hudecova M, Holte J, Olovsson M, Larsson A, Berne C & Sundstrom-Poromaa I. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up. Fertility and Sterility 2011 96 1271-1274. (doi:10.1016/j.fertnstert.2011.08.006)